29 participants
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2021-04-26
- Completion:
- 2026-07-10
Conditions
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Castration-Resistant Prostate Carcinoma
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- HER2-Positive Breast Carcinoma
- Locally Advanced Breast Carcinoma
- Locally Advanced Gastric Carcinoma
- Locally Advanced Malignant Solid Neoplasm
- Locally Advanced Ovarian Carcinoma
- Locally Advanced Pancreatic Carcinoma
- Locally Advanced Prostate Carcinoma
- Metastatic Breast Carcinoma
- Metastatic Gastric Carcinoma
- Metastatic Malignant Solid Neoplasm
- Metastatic Ovarian Carcinoma
- Metastatic Pancreatic Carcinoma
- Metastatic Prostate Carcinoma
- Platinum-Sensitive Ovarian Carcinoma
- Recurrent Breast Carcinoma
- Recurrent Gastric Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Pancreatic Carcinoma
- Recurrent Prostate Carcinoma
- Stage II Pancreatic Cancer AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage III Pancreatic Cancer AJCC v8
- Stage III Prostate Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
- Stage IV Prostate Cancer AJCC v8
Interventions
- PROCEDURE
- DRUG
No Results Yet